Founded in 2014, Slate Run Pharmaceuticals has built a strong and expanding presence in the U.S. generic pharmaceutical market. The company is led by a seasoned leadership team with over 200 years of combined industry experience across commercial operations, regulatory affairs, quality, and supply chain management. Slate Run’s team has been directly involved in the selection, FDA approval, commercialization, and supply of a broad portfolio of generic pharmaceuticals spanning multiple therapeutic areas.

Today, Slate Run markets more than 30 product families and serves customers across the U.S., including wholesalers, distributors, pharmacies, and healthcare providers. Through disciplined portfolio development, strategic manufacturing partnerships, and a commitment to regulatory compliance and supply reliability, Slate Run is dedicated to expanding patient access to high-quality, affordable medications while driving sustainable growth.

Slate Run Pharmaceuticals

Org chart

Teams

Offices